Although the mechanism of TCEs in treating hypertension is not clear, the increase in endogenous nitric oxide (NO) production and the decrease in endothelin-1 (ET-1) in plasma after TCEs therapy may be one of the main biological mechanisms of TCEs in treating essential hypertension (36). The gene discussed is EDN1; the disease is essential hypertension.